Histone Deacetylases (HDACs)

Introduction

Histone Deacetylases (Hdacs) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

flowchart TD
    entities_histone_deacetylase["Histone Deacetylases HDACs"]
    style entities_histone_deacetylase fill:#4fc3f7,stroke:#333,color:#000
    entities_histone_dea_0["Classification"]
    entities_histone_deacetylase -->|"includes"| entities_histone_dea_0
    style entities_histone_dea_0 fill:#81c784,stroke:#333,color:#000
    entities_histone_dea_1["Class I HDACs Zn2+-dependent"]
    entities_histone_deacetylase -->|"includes"| entities_histone_dea_1
    style entities_histone_dea_1 fill:#ef5350,stroke:#333,color:#000
    entities_histone_dea_2["Class IIa HDACs Zn2+-dependent"]
    entities_histone_deacetylase -->|"includes"| entities_histone_dea_2
    style entities_histone_dea_2 fill:#ffd54f,stroke:#333,color:#000
    entities_histone_dea_3["Class IIb HDACs Zn2+-dependent"]
    entities_histone_deacetylase -->|"includes"| entities_histone_dea_3
    style entities_histone_dea_3 fill:#ce93d8,stroke:#333,color:#000
    entities_histone_dea_4["Class III HDACs NAD+-dependent, Sirtuins"]
    entities_histone_deacetylase -->|"includes"| entities_histone_dea_4
    style entities_histone_dea_4 fill:#4fc3f7,stroke:#333,color:#000
    entities_histone_dea_5["Class IV HDACs"]
    entities_histone_deacetylase -->|"includes"| entities_histone_dea_5
    style entities_histone_dea_5 fill:#81c784,stroke:#333,color:#000

Histone deacetylases (HDACs) are enzymes that remove acetyl groups from lysine residues on histone proteins

Classification

Class I HDACs (Zn²⁺-dependent)

• HDAC1 (18q22): Primarily nuclear, expressed in most tissues

• HDAC2 (6q21): Neuronally enriched, critical for synaptic plasticity^{3Targeting HDACs: a promising therapy for Alzheimer's Disease2011}

• HDAC3 (5q31): Expressed in brain, associated with transcriptional repression

• HDAC8 (Xp11.23): Primarily in smooth muscle and heart

Class IIa HDACs (Zn²⁺-dependent)

• HDAC4 (2q37.3): Activity-dependent nuclear-cytoplasmic shuttling^{4The role of HDACs in the response of the brain to metabolic stress2022}

• HDAC5 (18q11): Neuronal activity-dependent function

• HDAC7 (12q13): Expressed in heart and skeletal muscle

• HDAC9 (7p15-p14): Expressed in brain and muscle

Class IIb HDACs (Zn²⁺-dependent)

• HDAC6 (Xp11.23): Primarily cytoplasmic, deacetylates α-tubulin^{5HDAC6 as a target for neurodegenerative diseases: what makes it different from classical HDACs? J Alzheimers Dis2013}

• HDAC10 (22q13): Lysosomal degradation

Class III HDACs (NAD⁺-dependent, Sirtuins)

• SIRT1-7: Deacetylases with diverse cellular functions^{6consolidation of memory. Nat Rev Neurosci. 2009;10(9):615-6202009}

Class IV HDACs

• HDAC11 (3p12): Least characterized

Normal Function in the Brain

Epigenetic Regulation

• Repress transcription by deacetylating histones

• Dynamic regulation of gene expression programs

• Critical for neuronal development and differentiation

Synaptic Plasticity

• HDAC2 negatively regulates memory formation^{3Targeting HDACs: a promising therapy for Alzheimer's Disease2011}

• HDAC2 and HDAC3 modulate synaptic plasticity

• Activity-dependent histone acetylation is crucial for LTP

Non-histone Targets

• p53, NF-κB, STAT3

• α-Tubulin (HDAC6)

• Heat shock proteins

Role in Neurodegenerative Diseases

Alzheimer’s Disease

• HDAC2 is elevated in AD brain and correlates with memory deficits^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}0

• HDAC6 aggregates in AD brain and affects tau pathology^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}1

• Class I HDACs promote Amyloid-Beta production^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}2

• HDAC inhibition improves memory in AD models^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}3

Parkinson’s Disease

• SIRT1 has neuroprotective effects^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}4

• HDAC inhibitors protect dopaminergic neurons

• α-Synuclein acetylation affects aggregation

Huntington’s Disease

• HDAC inhibitors are therapeutic candidates^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}5

• Mutant huntingtin interacts with HDACs

• Transcriptional dysregulation involves HDAC function

Amyotrophic Lateral Sclerosis (ALS)

• HDAC levels altered in motor neurons

• HDAC inhibitors show promise in preclinical models^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}6

Therapeutic Targeting

HDAC Inhibitors in Clinical Trials

Several HDAC inhibitors are being tested: ^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}7

• VPA (Valproic Acid): Class I inhibitor, tested in AD and ALS

• SAHA (Vorinostat): Approved for cancer, being repurposed

• CI-994: Being investigated for neurodegenerative diseases

Challenges

• Lack of brain-penetrant, isoform-selective inhibitors

• Side effects from broad HDAC inhibition

• Need for better understanding of isoform-specific functions

External Links

• HDAC Classification - Nature

• HDAC Inhibitors in Neurodegeneration - PMC

• Sirtuins and Neurodegeneration - Frontiers

Brain Atlas Resources

• Allen Human Brain Atlas: Histone Deacetylases expression search

• Allen Mouse Brain Atlas: Histone Deacetylases search

• Allen Cell Type Atlas: Transcriptomic cell type reference

• BrainSpan Developmental Transcriptome: Histone Deacetylases developmental expression

See Also

• Alzheimer’s Disease

• Amyloid-Beta Aggregation

• Tau Pathology

• Parkinson’s Disease

• ALS

• Huntington’s Disease

• Synaptic Dysfunction

• Epigenetics in AD

• Clinical Trials

• Entities Index

Background

The study of Histone Deacetylases (Hdacs) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. ^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}8

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. ^{1HDAC inhibitors and neurodegeneration: at the edge between magic bullets and magic poisons2010}9

Additional evidence sources: ^{2Histone acetylation: molecular mnemonics on chromatin2013}0 ^{2Histone acetylation: molecular mnemonics on chromatin2013}1 ^{2Histone acetylation: molecular mnemonics on chromatin2013}2